Search results for "OSA"

showing 10 items of 9388 documents

Pepsinogen Test for the Evaluation of Precancerous Changes in Gastric Mucosa: a Population-Based Study

2018

Aims: The aim of the study was to evaluate the rationale of blood pepsinogen (PG) testing in population based screening settings.Methods: Participants from a cross-sectional population-based study of cardiovascular risk factors in Latvia were invited to participate in the current study. Pepsinogen I and II were measured in blood samples taken during the initial study and at follow-up; upper gastrointestinal endoscopy was performed. There were three groups of patients: with moderately decreased (PG I< 70 ng/ml and PG I/PG II ratio < 3), with strongly decreased (PG I< 30 ng/ml and PG I/PG II ratio < 2), and with normal PG level. Biopsy with H. pylori detection was performed (updat…

AdultMalemedicine.medical_specialtyPopulationGastroenterologyEndoscopy GastrointestinalHelicobacter Infections03 medical and health sciences0302 clinical medicinePepsinStomach NeoplasmsPepsinogen AInternal medicine0502 economics and businessBiopsyPepsinogen CGastric mucosamedicineHumansMass ScreeningeducationMass screeningAgededucation.field_of_studyHelicobacter pyloribiologymedicine.diagnostic_testbusiness.industryStomach05 social sciencesGastroenterologyCancerMiddle AgedHelicobacter pyloribiology.organism_classificationmedicine.diseasemedicine.anatomical_structureDysplasiaElder Nutritional Physiological PhenomenaGastritisbiology.proteinFemale050211 marketing030211 gastroenterology & hepatologyAtrophybusinessJournal of Gastrointestinal and Liver Diseases
researchProduct

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

2007

Patients with neutropenia resulting from chemotherapy for acute myelogenous leukemia or the myelodysplastic syndrome are at high risk for difficult-to-treat and often fatal invasive fungal infections.In this randomized, multicenter study involving evaluators who were unaware of treatment assignments, we compared the efficacy and safety of posaconazole with those of fluconazole or itraconazole as prophylaxis for patients with prolonged neutropenia. Patients received prophylaxis with each cycle of chemotherapy until recovery from neutropenia and complete remission, until occurrence of an invasive fungal infection, or for up to 12 weeks, whichever came first. We compared the incidence of prove…

AdultMalemedicine.medical_specialtyPosaconazoleAntifungal AgentsNeutropeniaAdolescentItraconazolemedicine.medical_treatmentAntineoplastic AgentsKaplan-Meier EstimateOpportunistic InfectionsNeutropeniaInternal medicineClinical endpointmedicineHumansSingle-Blind MethodFluconazoleAgedAged 80 and overChemotherapyLeukopeniabusiness.industryMyelodysplastic syndromesGeneral MedicineMiddle AgedTriazolesmedicine.diseaseSurgeryLeukemia Myeloid AcuteTreatment OutcomeMycosesMyelodysplastic SyndromesFemaleItraconazolemedicine.symptombusinessFluconazolemedicine.drugNew England Journal of Medicine
researchProduct

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.

2006

ABSTRACT The pharmacokinetic profiles, safety, and efficacies of different dosing schedules of posaconazole oral suspension in patients with possible, probable, and proven refractory invasive fungal infection (rIFI) or febrile neutropenia (FN) were evaluated in a multicenter, open-label, parallel-group study. Sixty-six patients with FN and 32 patients with rIFI were randomly assigned to one of three posaconazole regimens: 200 mg four times a day (q.i.d.) for nine doses, followed by 400 mg twice a day (b.i.d.); 400 mg q.i.d. for nine doses, followed by 600 mg b.i.d.; or 800 mg b.i.d. for five doses, followed by 800 mg once a day (q.d.). Therapy was continued for up to 6 months in patients wi…

AdultMalemedicine.medical_specialtyPosaconazoleAntifungal AgentsNeutropeniaFeverNeutropeniaClinical TherapeuticsGastroenterologyPharmacokineticsInternal medicineMedicineHumansPharmacology (medical)Adverse effectMycosisAgedBone Marrow TransplantationPharmacologyLeukopeniabusiness.industryMiddle AgedTriazolesmedicine.diseaseSurgeryDiscontinuationInfectious DiseasesMycosesFemalemedicine.symptombusinessFebrile neutropeniamedicine.drugAntimicrobial agents and chemotherapy
researchProduct

Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal Disease

2014

ABSTRACT This was a phase 1B, dose-ranging, multicenter, pharmacokinetics, and safety study of cyclodextrin-based posaconazole intravenous (i.v.) solution administered through a central line to subjects at high risk for invasive fungal disease (part 1 of a 2-part study [phase 1B/3]). Initially, the safety and tolerability of single-dose posaconazole i.v. 200 mg ( n = 10) were compared with those of a placebo ( n = 11). Subsequently, 2 doses were evaluated, posaconazole i.v. 200 mg once daily (q.d.) ( n = 21) and 300 mg q.d. ( n = 24). The subjects received twice-daily (b.i.d.) posaconazole i.v. on day 1, followed by 13 days of posaconazole i.v. q.d., then 14 days of posaconazole oral suspen…

AdultMalemedicine.medical_specialtyPosaconazoleAntifungal AgentsPhases of clinical researchPharmacologyPlaceboGastroenterologyCohort StudiesPharmacokineticsInternal medicinemedicineHumansPharmacology (medical)DosingAgedPharmacologyDose-Response Relationship Drugbusiness.industryMiddle AgedTriazolesPharmaceutical SolutionsDose–response relationshipInfectious DiseasesMycosesTolerabilityInjections IntravenousCohortFemalebusinessmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Symptom course in inpatient and day clinic treatment of depression: Results from the INDDEP-Study.

2015

Abstract Background In major depression (MDD), hospital treatment is an option in more severe cases or if outpatient treatment failed. Psychosomatic hospitals in Germany provide treatment programs with multimodal psychotherapy, either in an inpatient or a day hospital setting. In the context of health care research, this study aimed (1) to compare characteristics of patients treated in psychosomatic day hospitals and inpatient units, (2) to compare the effectiveness of both treatment modalities. Methods A naturalistic design was chosen to achieve external validity. 604 consecutive patients were assessed at admission, discharge and a 3-month follow-up. Primary outcome was defined as a reduct…

AdultMalemedicine.medical_specialtyRandomizationContext (language use)External validityYoung AdultQuality of lifeGermanyHealth caremedicineHumansSomatoform DisordersDepression (differential diagnoses)AgedDepressive Disorder MajorInpatientsbusiness.industryBulimia nervosaReproducibility of ResultsMiddle Agedmedicine.diseaseAntidepressive AgentsPsychotherapyPsychiatry and Mental healthClinical PsychologyTreatment OutcomeEmergency medicineQuality of LifeDay hospitalFemalebusinessDay Care MedicalFollow-Up StudiesJournal of affective disorders
researchProduct

A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in…

2004

Summary Background  Topical application of clobetasol-17-propionate has been diffusely reported as an efficacious therapy in atrophic/erosive oral lichen planus (OLP), without exposing the patient to systemic side-effects. However, prolonged contact and respective topical effects on the oral mucosa should be avoided. Objectives  The aim of the present study was to evaluate efficacy and compliance of new lipid microspheres loaded with 0·025% of clobetasol propionate (formulation A) compared with a commonly used formulation (a sort of dispersion of a lipophilic ointment in a hydrophilic phase) with the same amount of drug (formulation B) in the topical treatment of OLP. Patients and methods  …

AdultMalemedicine.medical_specialtyRandomizationVisual analogue scaleAdministration TopicalChemistry PharmaceuticalAnti-Inflammatory AgentsDermatologyDosage formlaw.inventionOintmentsDrug Delivery SystemsRandomized controlled triallawMedicineHumansSingle-Blind MethodOral mucosaGlucocorticoidsAgedAged 80 and overClobetasolbusiness.industryMiddle Agedmedicine.diseaseDermatologyLipidsMicrospheresRegimenmedicine.anatomical_structureclobetasol propionate delivery lipid microspheres oral lichen planusPatient ComplianceOral lichen planusFemaleClobetasol propionatebusinessmedicine.drugLichen Planus OralThe British journal of dermatology
researchProduct

Lichenoid lesions of the upper lip: A retrospective study of 24 cases.

2017

Background Lichenoid lesions of the upper labial mucosa, without other oral or extraoral manifestations seem to be rare. The clinicopathologic features of 24 such cases are presented and the pertinent literature is reviewed. Material and Methods 24 Caucasian patients that clinically presented lichenoid features on the upper labial mucosa, with or without lichenoid lesions on the adjacent gingiva, were included in the study. Clinical features were extracted from the patients’ records, while dental plaque/calculus accumulation and composite resin restorations of the adjacent teeth were recorded. Four cases where an incisional biopsy was performed were further evaluated. Results There were 8 m…

AdultMalemedicine.medical_specialtyResin restorationsReviewDental plaque030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicinestomatognathic systemOral and maxillofacial pathologyMedicineHumansLabial MucosaGeneral DentistryLichenoid lesionsAgedRetrospective StudiesAged 80 and overOral Medicine and Pathologybusiness.industryCalculus (dental)Upper lipRetrospective cohort studyLip DiseasesMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Dermatology3. Good healthstomatognathic diseasesOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASSurgeryFemalebusinessLichen Planus OralMedicina oral, patologia oral y cirugia bucal
researchProduct

Transverse sacral fracture with intrapelvic intrusion of the lumbosacral spine: case report and review of the literature.

2000

AdultMalemedicine.medical_specialtySacrumLumbosacral spineCritical Care and Intensive Care MedicineIntrusionFracture Fixation InternalFractures BoneMedicineHumansSpinal Cord InjuriesPelvic girdleLumbar Vertebraebusiness.industryLaminectomyAnatomySacrumSacral fractureRadiographyOrthopedic surgerySpinal FracturesSurgeryLumbar spinebusinessBone PlatesLumbosacral jointThe Journal of trauma
researchProduct

Molecular detection of Helicobacter pylori in oral samples from patients suffering digestive pathologies

2010

Objective: to determine the simultaneous presence of H. pylori in both the oral cavity and gastric mucosal in patients suffering digestive pathologies and to establish the possible association between the presence of H. pylori in the oral cavity and the gingivoperiodontal pathology. Study design: Patients with gastric symptoms (case group) and asymptomatic patients (control group) seen at the Gastroenterology Department of Dr. Julio C. Perrando Hospital (Resistencia, Argentina) were selected. Dental plaque and saliva samples from both groups were obtained. In the case group, gastric biopsy samples were also taken. H. pylori was detected in gastric biopsies by histological stains, and Polyme…

AdultMalemedicine.medical_specialtySalivaPathologyAdolescentDigestive System DiseasesDental PlaqueDiseaseDental plaqueGastroenterologyAsymptomaticlaw.inventionYoung AdultlawInternal medicineMedicineHumansYoung adultRisk factorChildSalivaGeneral DentistryPolymerase chain reactionAgedMouthbiologyHelicobacter pyloribusiness.industryHelicobacter pyloriMiddle Agedbiology.organism_classificationmedicine.disease:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesOtorhinolaryngologyMolecular Diagnostic TechniquesGastric MucosaChild PreschoolUNESCO::CIENCIAS MÉDICASSurgeryFemalemedicine.symptombusiness
researchProduct

Mucosal immunity and upper respiratory tract symptoms in recreational endurance runners.

2015

The present study investigated the effects of a 12-week endurance-training intervention on salivary proteins and upper respiratory tract symptoms (URS) in 25 young men. Saliva samples of 25 recreational male endurance runners (age 34.6 years, body mass index = 23.8 kg·m−2, peak aerobic capacity = 47.2 mL·kg−1·min−1) were collected before (PRE) and after (POST) the training intervention, in a fasting state, as well as both before and after a maximal incremental treadmill run. The training consisted of both continuous and interval training sessions, 4–6 times per week based on the polarized training approach. Participants filled in Wisconsin Upper Respiratory Symptom Survey-21 and were retro…

AdultMalemedicine.medical_specialtySalivaPhysiologyEndocrinology Diabetes and MetabolismRespiratory SystemRespiratory Tract DiseasesGastroenterologyInterval trainingBody Mass IndexRunning03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineWisconsinEndurance trainingPhysiology (medical)Internal medicineSurveys and QuestionnairesMedicineHumansRespiratory systemTreadmillSalivaImmunity MucosalDisease ResistanceRetrospective StudiesNutrition and Dieteticsbusiness.industryBody Weight030229 sport sciencesGeneral MedicineImmunoglobulin AEndocrinologyImmunoglobulin MSalivary alpha-AmylasesPhysical EnduranceSalivary alpha-AmylasesbusinessBody mass index030217 neurology & neurosurgeryBiomarkersApplied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
researchProduct